Dexmedetomidine Hydrochloride Injection, Solution, Concentrate
Product Images NDC 36000-262

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Dexmedetomidine Hydrochloride (NDC 36000-262). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton-3 (Carton 3)

Packaging label for Dexmedetomidine Injection, USP 100 mcg/mL (200 mcg/2 mL) concentrate for injection. The label indicates it is preservative free, for intravenous use, and packaged as 5 x 2 mL single-dose vials. Manufactured by Baxter Pharmaceuticals India Pvt Ltd for Baxter Healthcare Corporation. Storage and dosage instructions are included.*

FDA Label Image

Carton-4 (Carton 4)

Packaging label for Dexmedetomidine Injection, USP 200 mcg/2 mL (100 mcg/mL) concentrate solution for intravenous use. The product is preservative-free and intended for dilution before use. The label indicates a package size of 10 x 2 mL single-dose vials. The manufacturer is Baxter Pharmaceuticals India Private Ltd, and it is manufactured for Baxter Healthcare Corporation. The NDC is 36000-262-10.*

FDA Label Image

Carton-5 (Carton 5)

Packaging label for Dexmedetomidine Injection, USP 200 mcg/2 mL (100 mcg/mL) concentrate injection for intravenous use by Baxter Healthcare Corporation. The label states it is preservative-free, Rx only, and must be diluted before use. It contains 25 single-dose vials of 2 mL each. Storage instructions and formulation details are included.*

FDA Label Image

Container-2 (Container 2)

Label for Dexmedetomidine Injection, USP 200 mcg/2 mL (100 mcg/mL), an intravenous injection solution concentrate in a 2 mL single-dose vial. The label indicates the product must be diluted before use, identifies Baxter Healthcare Corporation as the manufacturer, and includes dosage instructions, lot number, expiration date, and a barcode.*

FDA Label Image

Description-1 (Description 1)

Chemical structure of dexmedetomidine hydrochloride, depicting its molecular framework including an imidazole ring, aromatic ring with methyl groups, and hydrochloride component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.